CM
PFE icon

Capula Management’s Pfizer PFE Stock Holding History

Capula Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.44M Buy
267,600
+240,400
+884% +$6.29M 0.02% 163
2026
Q1 		$764K Buy
27,200
+100
+0.4% +$2.66K 0.01% 415
2025
Q4 		$675K Sell
27,100
-14,800
-35% -$373K ﹤0.01% 350
2025
Q3 		$1.07M Sell
41,900
-124,600
-75% -$3.08M 0.01% 352
2025
Q2 		$4.04M Sell
166,500
-9,600
-5% -$224K 0.04% 84
2025
Q1 		$4.46M Buy
176,100
+169,200
+2,452% +$4.43M 0.02% 148
2024
Q4 		$183K Buy
+6,900
New +$187K ﹤0.01% 309
2024
Q3 		– Sell
-11,600
Closed -$325K – 606
2024
Q2 		$325K Buy
+11,600
New +$319K ﹤0.01% 361
2023
Q4 		– Sell
-22,100
Closed -$733K – 520
2023
Q3 		$733K Buy
+22,100
New +$782K 0.02% 278
2023
Q2 		– Sell
-244,800
Closed -$9.99M – 704
2023
Q1 		$9.99M Sell
244,800
-528,000
-68% -$22.8M 0.12% 149
2022
Q4 		$39.6M Buy
772,800
+541,600
+234% +$26M 0.53% 45
2022
Q3 		$10.1M Sell
231,200
-257,600
-53% -$12.5M 0.14% 176
2022
Q2 		$25.6M Buy
488,800
+232,400
+91% +$11.8M 0.44% 65
2022
Q1 		$13.3M Buy
+256,400
New +$13.3M 0.19% 109
2021
Q4 		– Sell
-93,400
Closed -$4.02M – 631
2021
Q3 		$4.02M Sell
93,400
-49,800
-35% -$2.21M 0.05% 268
2021
Q2 		$5.56M Buy
143,200
+111,200
+348% +$4.32M 0.09% 177
2021
Q1 		$1.16M Buy
+32,000
New +$1.14M 0.02% 338
2020
Q3 		– Sell
-649,475
Closed -$20.1M – 282
2020
Q2 		$20.1M Buy
649,475
+190,985
+42% +$6.49M 0.72% 27
2020
Q1 		$14.2M Buy
458,490
+233,566
+104% +$7.96M 0.51% 52
2019
Q4 		$8.36M Buy
+224,924
New +$8.01M 0.18% 127

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capula Management's PFE Position: Q2 2026 in Review

Capula Management increased its Pfizer (PFE) stake by 18,226% in Q2 2026, buying an estimated $4.43M and bringing the position to 170,245 shares worth $4.1M. The position accounts for 0.01% of the portfolio, ranked #190.

Capula Management first reported a position in PFE in Q1 2020 and has held it in 18 quarters since. The position peaked at $9.97M in Q2 2020. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Capula Management held 170,245 shares of Pfizer worth $4.1M as of Q2 2026.
  • Capula Management bought 169,316 Pfizer shares in Q2 2026, an estimated $4.43M.
  • Pfizer made up 0.01% of Capula Management's portfolio in Q2 2026, its #190 holding.
  • Capula Management first reported a position in Pfizer in Q1 2020 and has held it in 18 quarters since.
  • Capula Management's Pfizer position peaked at $9.97M in Q2 2020.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.